The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season. Moderna, the vaccine's maker
Coverage spectrum
Read at your length
The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season. Moderna, the vaccine's maker
The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season. The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic, said the manufacturer, Moderna. The shot, named mFlusiva, is intended for adults who are 50 and older.
NPR reported the story as "A new flu vaccine geared to older people is coming soon."
2 sources have covered this story, including NPR and Fast Company. The earliest reporting in the cluster landed about 1 day ago.
How each side is reporting it
How the left is reporting it
How the wires + center are reporting it
Emphasizes · omits ▾
- On-the-record fact pattern, primary documents, dollar figures, named officials.
- Frame-setting context that explicitly partisan desks foreground.
How the right is reporting it
Where sources agree
No shared facts cached yet.
Where they diverge
No contradictions cached yet.
Claim ledger
[01] VerifiedCore event reported by 2 independent outlets across the spectrum.
[02] DisputedKey facts present in mainstream desks; corroboration thin from wires.